MedTrace Logo

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

NCT00168480 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 424

Last updated 2008-09-29

No results posted yet for this study

Summary

This is a three year open-label study in subjects with axillary hyperhidrosis.

Conditions

  • Hyperhidrosis

Interventions

BIOLOGICAL

Botulinum Toxin Type A

100 U, repeated treatments at \> 4 month intervals up to Month 32, over a 36-month study period

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States
  • Germany
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168480 on ClinicalTrials.gov